Last updated 2026-09-02
- Acquired by Stryker for $220M, Mar 2019
- Raised $7M Series C led by Triventures, Dec 2016
- Raised $8M Series B led by HealthpointCapital, May 2015
Total raised
$15.0M
Last: B Round 2016-12
Stage
Acquired
Founded
2009
Headcount
6
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
OrthoSpace developed and commercialized a biodegradable balloon system, InSpace, for the treatment of massive irreparable rotator cuff tears. The InSpace product is a biodegradable sub-acromial spacer, which is designed to realign the natural biomechanics of the shoulder, reduce pain, and improve range of motion. The company was acquired by Stryker in 2019. In July 2021, the InSpace system received FDA clearance in the U.S.
Funding history · 2 rounds · $15.0M total
2 events/rounds · $15.0M Total Funding: $15.0M in Private Equity
Dec 2016
May 2015
★ HealthpointCapital★ Healthpoint CapitalVSLIAJJSViasciArthocareArthroCareTriventuresSmith & NephewSmith and Nephew
Headcount over time
6 employees (2026-09) · 1 point
Offices
Caesarea, Israel · HQ / main office
Q&A
- What is OrthoSpace's primary product?
- OrthoSpace developed and commercialized the InSpace biodegradable balloon system for the treatment of massive irreparable rotator cuff tears. This system is designed to realign shoulder biomechanics, reduce pain, and improve range of motion.
- When was OrthoSpace acquired and by whom?
- OrthoSpace was acquired by Stryker in March 2019 for $220 million.
- What was OrthoSpace's last known funding round before its acquisition?
- OrthoSpace completed a B Round in December 2016, raising $7 million. Key investors in this round included HealthpointCapital LLC and Johnson & Johnson Innovation - JJDC, Inc.
- When did the InSpace system receive FDA clearance in the U.S.?
- The InSpace system received FDA clearance in the U.S. in July 2021.
- How much capital did OrthoSpace raise in total?
- OrthoSpace raised a total of $23.6 million across its funding rounds.
- Who are some of the lead investors in OrthoSpace's B Round in May 2015?
- In May 2015, OrthoSpace completed a B Round that included investments from HealthpointCapital and Smith & Nephew.
- Where is OrthoSpace headquartered?
- OrthoSpace is headquartered in Caesarea, Israel.
- What is the employee count for OrthoSpace?
- OrthoSpace has an employee count in the 11-50 range.
Team · 5
Assaf Dekel
Founder · Co-Founder & Medical Director
Itay Barnea
CEO
Yossi Ben-Zaken
CFO
Yoav Meiraz
COO
Ruth Icekson
Marketing Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Highlights
Patents
Tags
medical-technologiesminimally-invasivebiodegradableorthopedicsrehabilitationhealthcare-providerspain-reliefpatientsmedical-devicesbiomaterialstreatmentsrotator-cuff-repairsports-medicine
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | orthospace.co.il |
|---|---|
| linkedin.com/company/2142019 |
Identifiers & details
| Legal name | OrthoSpace, Ltd. |
|---|---|
| Founded | 2009 |
| Employees (exact) | 6 |
Acquisitions & public offerings
Acquired by Stryker 2019-03 $220.0M
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | orthospace.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|